These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11407442)

  • 21. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive psychosocial therapies for the treatment of schizophrenia.
    Patterson TL; Leeuwenkamp OR
    Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch
    MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates.
    Hogarty GE; Kornblith SJ; Greenwald D; DiBarry AL; Cooley S; Ulrich RF; Carter M; Flesher S
    Am J Psychiatry; 1997 Nov; 154(11):1504-13. PubMed ID: 9356557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment.
    Schooler NR; Keith SJ; Severe JB; Matthews SM; Bellack AS; Glick ID; Hargreaves WA; Kane JM; Ninan PT; Frances A; Jacobs M; Lieberman JA; Mance R; Simpson GM; Woerner MG
    Arch Gen Psychiatry; 1997 May; 54(5):453-63. PubMed ID: 9152099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family intervention in schizophrenia--impact on family burden and attitude.
    Berglund N; Vahlne JO; Edman A
    Soc Psychiatry Psychiatr Epidemiol; 2003 Mar; 38(3):116-21. PubMed ID: 12616308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E
    Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
    [No Abstract]   [Full Text] [Related]  

  • 30. 'Psychosocial' interventions with families and their effects on the course of schizophrenia: a review.
    Barrowclough C; Tarrier N
    Psychol Med; 1984 Aug; 14(3):629-42. PubMed ID: 6149587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
    Reznik I; Sirota P
    J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ;
    J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Crisp K; Newman B; Spiliotacopoulos D; McGorry PD
    J Clin Psychiatry; 2010 Apr; 71(4):475-83. PubMed ID: 20021994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
    Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
    J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.
    Schooler NR; Keith SJ; Severe JB; Matthews SM
    Psychiatr Q; 1995; 66(4):279-92. PubMed ID: 8584586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?
    Gaebel W; Frick U; Köpcke W; Linden M; Müller P; Müller-Spahn F; Pietzcker A; Tegeler J
    Br J Psychiatry Suppl; 1993 Sep; (21):8-12. PubMed ID: 8105814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection and intervention in schizophrenia.
    Linszen DH; Dingemans PM; Lenior ME; Scholte WF; de Haan L; Goldstein MJ
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S31-4. PubMed ID: 9690968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
    Shriqui CL
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.